Lung Cancer: A Wily Genetic Opponent
- PMID: 28525750
- DOI: 10.1016/j.cell.2017.05.001
Lung Cancer: A Wily Genetic Opponent
Abstract
In two companion reports, the TRACERx consortium investigates tumor heterogeneity and evolution in early-stage non-small cell lung cancer. The studies highlight the prognostic value of copy-number heterogeneity assessment in tumor biopsies and circulating tumor DNA detection in plasma and suggest that tracking the evolution of lung cancers might aid clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Tracking the Evolution of Non-Small-Cell Lung Cancer.N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26. N Engl J Med. 2017. PMID: 28445112
-
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364. Nature. 2017. PMID: 28445469 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical